Rethinking the Assessment of Arthrogenic Muscle Inhibition After ACL Reconstruction: Implications for Return-to-Sport Decision-Making—A Narrative Review
Journal of Clinical Medicine · 11.04.2025 · 14 (8) · 2633
DOI: 10.3390/jcm14082633 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Clinical Medicine, online erschienen am 11.04.2025. Verfasst von Florian Forelli und 4 weiteren Autor:innen. Beteiligte Einrichtung: Haute-Ecole Arc Santé, HES-SO University of Applied Sciences and Arts Western Switzerland, 2800 Delémont, Switzerland. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Arthrogenic muscle inhibition (AMI) is a neuromuscular impairment commonly observed following anterior cruciate ligament reconstruction (ACLR). This condition, characterized by persistent quadricep inhibition due to altered afferent feedback, significantly impacts neuromuscular recovery, delaying return to running and sport. Despite advancements in rehabilitation strategies, AMI may persist for months or even years after ACLR, leading to muscle strength asymmetries, altered biomechanics, and an increased risk of reinjury. The mechanisms underlying AMI involve both peripheral (joint effusion, mechanoreceptor dysfunction) and central (corticospinal inhibition, neuroplasticity alterations) components, which collectively hinder voluntary muscle activation and movement control. AMI alters gait mechanics, reduces knee stability, and promotes compensatory patterns that increase injury risk. Current return-to-sport protocols emphasize strength symmetry and functional performance but often neglect neuromuscular deficits. A comprehensive assessment integrating neuromuscular, biomechanical, and proprioceptive evaluations is needed at specific stages to optimize rehabilitation and minimize reinjury risk. Future research should explore targeted interventions such as neuromuscular stimulation, cognitive–motor training, and advanced gait analysis to mitigate AMI’s impact and facilitate a safer, more effective return to sport.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Haute-Ecole Arc Santé, HES-SO University of Applied Sciences and Arts Western Switzerland, 2800 Delémont, Switzerland.
- Orthopaedic Surgery Department, Clinic of Domont, Ramsay Healthcare, @OrthoLab, 95330 Domont, France.
- Société Française des Masseurs-Kinésithérapeutes du Sport Lab, 93380 Pierrefite sur Seine, France.
- Orthosport Rehab Center, 95330 Domont, France.
ORCID-Profile: Florian Forelli, Ayrton Moiroux-Sahraoui, Jean Mazeas, Jonathan Dugernier
Zitieren
APA
Forelli, F., Moiroux-Sahraoui, A., Mazeas, J., Dugernier, J., & Cerrito, A. (2025). Rethinking the Assessment of Arthrogenic Muscle Inhibition After ACL Reconstruction: Implications for Return-to-Sport Decision-Making—A Narrative Review. Journal of Clinical Medicine, 14(8), 2633. https://doi.org/10.3390/jcm14082633
Vancouver
Forelli F, Moiroux-Sahraoui A, Mazeas J, Dugernier J, Cerrito A. Rethinking the Assessment of Arthrogenic Muscle Inhibition After ACL Reconstruction: Implications for Return-to-Sport Decision-Making—A Narrative Review. Journal of Clinical Medicine. 2025;14(8):2633. doi:10.3390/jcm14082633
BibTeX
@article{Forelli2025,
author = {Forelli, Florian and Moiroux-Sahraoui, Ayrton and Mazeas, Jean and Dugernier, Jonathan and Cerrito, Adrien},
title = {Rethinking the Assessment of Arthrogenic Muscle Inhibition After ACL Reconstruction: Implications for Return-to-Sport Decision-Making—A Narrative Review},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {8},
pages = {2633},
doi = {10.3390/jcm14082633}
}
EUVIMED